← Leaderboards
Brian D. Green
Glycobia, Inc.
$1,216,474
Attributed
$1,216,474
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $766.5K · FY2016–19$1M$750K$500K$250K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$1,216,474 · 3
By mechanism
R44$766,474 · 1
R43$450,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroEscherichia ColiTechnologyProductionGenerationsGlycoconjugatesPolysaccharidesResponseGlycosylationProteinsImmuneEngineeringBindingAffinityEpitopesCell SurfaceAntibodiesCarrier ProteinsCollaborationsCarbohydratesBaseAnabolismBiological ProductsAnimals
Grant awards (3)
Novel strategy to generate glycan-specific antibodies for cancer immunotherapy$300,000
R43 · FY2019 · CA · contact PI
N-glycan specific antibodies for advancing glycobiology research$150,000
R43 · FY2017 · GM · contact PI
Glycoconjugate therapeutic peptides for improved treatment of human diseases$766,474
R44 · FY2016 · GM · contact PI